Home-based Oral Glucose Tolerance Test for Type 1 Diabetes Screening
Launched by YALE UNIVERSITY ·
Trial Information
Current as of October 02, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new way to test for Type 1 Diabetes using a simple fingerstick blood test that people can do at home. The goal is to see how accurate this home test is compared to the standard test done in a clinic, where blood is drawn from a vein after drinking a sugary drink. This study is for people who may be at risk for Type 1 Diabetes—specifically, those who have certain antibodies in their blood that suggest they might develop the condition—or for those who have recently been diagnosed with early-stage Type 1 Diabetes.
If you are interested in joining, you should be between the ages of about 29 and 16,435 (this seems like a typo, so likely it means ages 2 to 18 or similar) and either have these antibodies or have been diagnosed with Type 1 Diabetes within the last 100 days. Participants will be asked to perform the home fingerstick test and also come in for the usual clinic test so researchers can compare the results. This study could help make diabetes screening easier and more convenient in the future by allowing people to test themselves at home.
Gender
ALL
Eligibility criteria
About Yale University
Yale University, a prestigious Ivy League institution located in New Haven, Connecticut, is renowned for its commitment to advancing medical research and clinical innovation. With a rich history of academic excellence and a robust infrastructure for scientific inquiry, Yale serves as a leading sponsor for clinical trials aimed at improving patient care and developing new therapeutic approaches. The university's multidisciplinary teams of researchers and clinicians collaborate to conduct rigorous and ethical studies, leveraging cutting-edge technologies and methodologies to address critical health challenges. Through its dedication to fostering an environment of inquiry and discovery, Yale University plays a pivotal role in translating research findings into clinical practice, ultimately enhancing health outcomes for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Alfonso Galderisi, MD
Principal Investigator
Yale University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported